ArticleNature communications2025

Budesonide-incorporated inhalable lipid nanoparticles for antiTSLP nanobody mRNA delivery to treat steroid-resistant asthma.

Jia Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.